The presentation will include an update on the momentum and business progress made by the company and look ahead at the coming news flow for the new year. Management will give an overall update on the company's pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating brain and prostate cancer.
The presentation will be webcasted live 15:05-15:25 (CET),
For more information - please click here
For more information regarding
Phone: +45 22 83 01 60
E-mail: uk@curasight.com
www.curasight.com
https://news.cision.com/curasight/r/curasight-to-present-at-redeye-fight-cancer-seminar,c3698082
https://mb.cision.com/Main/19744/3698082/1781746.pdf
(c) 2023 Cision. All rights reserved., source